| Description | OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to
the development of compounds which modify the human microbiome - the collective
genome of the microbes in the body - in order to prevent and manage human disease
and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the
development of microbial strains, compounds, and formulations which are used as active
ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human
microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products. The Companys current areas of focus include obesity, cardiovascular health, and
diabetes.
Additional info from OTC:
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to
the development of compounds which modify the human microbiome - the collective
genome of the microbes in the body - in order to prevent and manage human disease
and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the
development of microbial strains, compounds, and formulations which are used as active
ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human
microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products. The Companys current areas of focus include obesity, cardiovascular health, and
diabetes. |
|---|